Ohm Pancreas Aid

Helonias Dioica, Lacticum Acidum, Pancreas Suis, Pancreatinum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Thyroidinum, Uranium Nitricum.

Ohm Pharma Inc.
Human Otc Drug
NDC 66096-153

Ohm Pancreas Aid also known as Helonias Dioica, Lacticum Acidum, Pancreas Suis, Pancreatinum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Thyroidinum, Uranium Nitricum. is a human otc drug labeled by 'Ohm Pharma Inc.'. National Drug Code (NDC) number for Ohm Pancreas Aid is 66096-153. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Ohm Pancreas Aid drug includes Chamaelirium Luteum Root - 30 [hp_C]/59mL Lactic Acid, Dl- - 4 [hp_X]/59mL Pancrelipase - 14 [hp_X]/59mL Phosphoric Acid - 10 [hp_X]/59mL Phosphorus - 10 [hp_X]/59mL Sus Scrofa Pancreas - 8 [hp_X]/59mL Syzygium Cumini Seed - 3 [hp_X]/59mL Thyroid, Unspecified - 8 [hp_X]/59mL Uranyl Nitrate Hexahydrate - 12 [hp_X]/59mL . The currest status of Ohm Pancreas Aid drug is Active.

Drug Information:

Drug NDC:	66096-153
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Ohm Pancreas Aid
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Helonias Dioica, Lacticum Acidum, Pancreas Suis, Pancreatinum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Thyroidinum, Uranium Nitricum.
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Ohm Pharma Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	CHAMAELIRIUM LUTEUM ROOT - 30 [hp_C]/59mL LACTIC ACID, DL- - 4 [hp_X]/59mL PANCRELIPASE - 14 [hp_X]/59mL PHOSPHORIC ACID - 10 [hp_X]/59mL PHOSPHORUS - 10 [hp_X]/59mL SUS SCROFA PANCREAS - 8 [hp_X]/59mL SYZYGIUM CUMINI SEED - 3 [hp_X]/59mL THYROID, UNSPECIFIED - 8 [hp_X]/59mL URANYL NITRATE HEXAHYDRATE - 12 [hp_X]/59mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	03 Aug, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	06 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	OHM PHARMA INC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0366096153052
UPC stands for Universal Product Code.
UNII:	DQV54Y5H3U 3B8D35Y7S4 FQ3DRG0N5K E4GA8884NN 27YLU75U4W 9Y3J3362RY 820LSF646I 0B4FDL9I6P 3V057702FY
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
66096-153-05	59 mL in 1 BOTTLE, SPRAY (66096-153-05)	03 Aug, 2015	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Ohm Pancreas Aid

Helonias Dioica & more..

Liquid
OHM PHARMA INC.
NDC: 66096-153

Purpose:

Relieves metabolic pancreas dysfunctions.

Product Elements:

Ohm pancreas aid helonias dioica, lacticum acidum, pancreas suis, pancreatinum, phosphoricum acidum, phosphorus, syzygium jambolanum, thyroidinum, uranium nitricum. alcohol glycerin water chamaelirium luteum root chamaelirium luteum root lactic acid, dl- lactic acid, dl- sus scrofa pancreas sus scrofa pancreas pancrelipase pancrelipase lipase phosphoric acid phosphoric acid phosphorus phosphorus syzygium cumini seed syzygium cumini seed thyroid, unspecified thyroid, unspecified uranyl nitrate hexahydrate uranium cation (6+)

Indications and Usage:

Uses: temporarily relieves metabolic pancreas dysfunctions.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: if pregnant or breast-feeding, ask a health professional before use. if symptoms worsen or persist for more than a week, discontinue use and contact a doctor. âkeep out of reach of children.

Dosage and Administration:

Directions: shake 10 times before use. adults & children above 12 years of age: spray 3-4 times under the tongue 2-3 times a day, or as directed by a health care professional. children under 12 years: use half the adult dose.

Package Label Principal Display Panel:

Homeopathic medicine ndc: 66096-153-05 pancreas aid natural - safe - effective no side effects 2 fl oz (59 ml) / 15% alcohol 2oz bottle label relieves metabolic pancreas dysfunctions.

Further Questions:

Mfg. by: ohm pharma, inc. mineral wells, tx 76067 www.ohmpharma.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.